Free Prostate Specific Antigen (fPSA) Test

The Free Prostate Specific Antigen (fPSA) test measures the levels of free PSA in the blood. PSA is a protein produced by the prostate gland, and it exists in two forms in the blood—bound PSA and free PSA. This test helps distinguish between prostate cancer and benign prostate conditions such as benign prostatic hyperplasia (BPH). A lower percentage of free PSA is often associated with a higher likelihood of prostate cancer, making this test useful for further investigation after a total PSA test.

Free Prostate Specific Antigen (fPSA) Test

  • Code: MLFPSA

Tests Included

This test evaluates the level of free PSA in the bloodstream. Comparing the ratio of free to total PSA helps to differentiate between benign and malignant prostate conditions, offering additional insight into prostate cancer diagnosis.

Free Prostate Specific Antigen

FAQs

The fPSA test is recommended if you have elevated total PSA levels or are experiencing symptoms of prostate issues. It helps differentiate between prostate cancer and benign conditions such as BPH and can guide the next steps in diagnosis or treatment.

A blood sample is collected from a vein in your arm, and the levels of free PSA are measured in the lab.

Results are typically available within 1–2 working days. You will be notified by email or text once your results are ready.

No special preparation is needed for the fPSA test. However, let your healthcare provider know if you’re taking any medications or have had any prostate-related treatments that could influence the results.

Book Free Prostate Specific Antigen (fPSA) Test Today!

 

Take control of your prostate health with the Free Prostate Specific Antigen (fPSA) test. Get valuable insights into your prostate condition and assess the next steps in care..

Contact Us

If the information you are looking for is not available here, please contact us. Additionally, follow us on our social media platforms for updates and more information:

 

LinkedIn Facebook X Instagram and YouTube.